Shelter Pharma Ltd
BSE: 543963
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q2 FY26 | Q4 FY25 | Q2 FY25 | Q4 FY24 | Q2 FY24 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 33.29+25.1% | 26.60+10.6% | 24.06+16.2% | 20.71+7.2% | 19.31 |
| Other Income | 0.01+66.7% | 0.00+50.0% | 0.00-33.3% | 0.00+200.0% | 0.00 |
| Total Income | 33.30+25.1% | 26.61+10.6% | 24.06+16.2% | 20.71+7.2% | 19.31 |
| EXPENSES | |||||
| Expenditure | 27.28+26.0% | 21.66+12.1% | 19.33+17.6% | 16.43+8.1% | 15.19 |
| Tax | 1.51+21.6% | 1.25+4.2% | 1.20+14.4% | 1.04+2.6% | 1.02 |
| PROFIT | |||||
| PBT | 6.01+21.6% | 4.95+4.5% | 4.73+13.6% | 4.16+1.0% | 4.12 |
| Net Profit | 4.50+21.6% | 3.70+4.7% | 3.54+13.4% | 3.12+0.5% | 3.10 |
| KEY METRICS | |||||
| OPM % | 17.30%-0.42pp | 17.72%-1.24pp | 18.96% | — | 20.46% |
| NPM % | 13.52%-0.39pp | 13.91%-0.79pp | 14.70%-0.35pp | 15.05%-1.01pp | 16.06% |
| EPS | 3.89+21.6% | 3.20+4.6% | 3.06+13.3% | 2.70+0.7% | 2.68 |
Corporate Events
Board Meeting
The Board of Directors considered and approved the conversio…
BSE Filing ↗Board Meeting
The company has issued a notice for its 19th Annual General …
BSE Filing ↗Board Meeting
The Board of Directors discussed and approved the regulariza…
BSE Filing ↗Board Meeting
The Board of Directors discussed, approved, and took on reco…
BSE Filing ↗Board Meeting
To consider and approve the Audited Financial Results for th…
BSE Filing ↗Board Meeting
To consider and approve to raise funds by way of issue of Co…
BSE Filing ↗Board Meeting
fund raising through the issue of equity shares of the Compa…
BSE Filing ↗Board Meeting
fund raising, proposal evaluation, approval, other
BSE Filing ↗Board Meeting
Consider, approve and take on record Unaudited Standalone Fi…
BSE Filing ↗Board Meeting
To consider, approve and take on record the Audited Financia…
BSE Filing ↗